Tyrosine kinase inhibition differentially regulates heterologously expressed HCN channels

Han-Gang Yu1, Zhongju Lu, Zongming Pan

  • 1New York College of Osteopathic Medicine of New York Institute of Technology, New York, NY, USA. hgyu@nyit.edu

Insights

Tyrosine kinase inhibitor genistein differentially affects cardiac HCN channel isoforms. Genistein reduces HCN2 and HCN4 currents, impacting heart rhythm regulation by altering pacemaker current properties.

Area of Science:

  • Cardiovascular Physiology
  • Molecular Cardiology
  • Ion Channel Biology

Background:

  • Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, specifically HCN1, HCN2, and HCN4, are crucial for cardiac pacemaker current i(f).
  • Previous research indicated HCN4 is dominant in the sinoatrial (SA) node, and tyrosine phosphorylation influences i(f) conductance.
  • HCN2 is identified as the predominant isoform in rat ventricular myocytes.

Purpose of the Study:

  • To investigate the effect of genistein, a tyrosine kinase inhibitor, on heterologously expressed HCN currents.
  • To determine if genistein alters HCN2 and HCN4 currents and their activation kinetics and voltage dependence.
  • To test the hypothesis that genistein reduces i(f) in rat ventricular myocytes, shifting voltage dependence and activation kinetics.

Main Methods:

  • Xenopus oocytes expressing HCN1, HCN2, or HCN4 were studied using whole-cell patch-clamp electrophysiology.
  • Genistein's effects on current density, activation kinetics, and voltage dependence were analyzed.
  • Isolated rat ventricular myocytes were used to assess genistein's impact on endogenous i(f) current.

Main Results:

  • Genistein reduced HCN2 and HCN4 currents and slowed their activation kinetics, with no effect on HCN1.
  • HCN2 currents showed a negative shift in voltage dependence of activation with genistein treatment.
  • In rat ventricular myocytes, genistein significantly reduced i(f) current density and shifted activation midpoint negatively.

Conclusions:

  • Cardiac i(f) and related currents in other tissues are differentially regulated by tyrosine phosphorylation.
  • Isoform-specific effects of genistein on HCN channels suggest distinct roles in cardiac electrophysiology.
  • Tyrosine phosphorylation represents a potential regulatory mechanism for cardiac pacemaker function.

Related Concept Videos

Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Enzyme-linked Receptors01:13

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...